Cortexin
Polypeptide bioregulator derived from the cerebral cortex of cattle and pigs. Contains low-molecular-weight neuropeptides that exhibit tissue-specific regulatory activity on cortical neurons. Proposed mechanisms include GABA-ergic and glutamatergic neuromodulation, antioxidant enzyme upregulation (superoxide dismutase, glutathione peroxidase), and reduction of excitotoxic cell death. Extensive Russian and CIS clinical data across pediatric and adult neurology indications.
Three tiers ordered by aggressiveness. Tier chips on every OPTIMIZE intervention let you filter the catalog by your evidence tolerance.
- alt
- ast
- hs-crp
- bovine-protein-allergy
- pregnancy
- lactation
- PMID:18709786Cortexin in the treatment of epilepsy in children — Zh Nevrol Psikhiatr Im S S Korsakova, 2008
- PMID:15202207The use of Cortexin in the complex treatment of cerebrovascular diseases — Zh Nevrol Psikhiatr Im S S Korsakova, 2004
- PMID:21526738Neuroprotective and nootropic effects of Cortexin — Neurosci Behav Physiol, 2011
Cortexin is Cerebrolysin's less famous sibling. Bovine cortex-derived rather than porcine whole-brain. The Russian clinical literature runs deep — cerebrovascular disease, pediatric neurology, cognitive rehabilitation. Western data is sparse, which locks it at Tier 2 despite decades of clinical use in the CIS. The 10-day IM protocol at 10mg/day is the standard cycle, repeated 2-4 times per year. If Cerebrolysin is the broadband neurotrophic signal, Cortexin is the cortex-specific modulator. The tissue-origin specificity of peptide bioregulators is a framework the Western pharmacological tradition has not fully engaged with.
This is not medical advice
Discuss with a licensed clinician before starting, stopping, or changing any compound. This page documents what the research literature describes — it is not a prescription.
See Cortexin in a protocol matched to you